Skip to main content
Bioceltix S.A. logo

Bioceltix S.A. — Investor Relations & Filings

Ticker · BCX ISIN · PLBCLTX00019 LEI · 259400QZD5JYK8SLZU51 WAR Manufacturing
Open in API
Filings indexed 287 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country PL Poland
Listing WAR BCX

About Bioceltix S.A.

https://bioceltix.com/en/

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Recent filings

Filing Released Lang Actions
Klauzula informacyjna dot. przetwarzania danych osobowych
Regulatory Filings Classification · 85% confidence The document is a privacy notice (clause) describing personal data processing under GDPR for shareholders and proxies in relation to the company’s general meetings. It does not contain financial results, voting outcomes, management changes, or meeting materials/agenda. It is a regulatory compliance disclosure rather than an AGM presentation, report, or proxy statement. Thus it falls under the general Regulatory Filings category (RNS).
2026-05-26 Polish
Informacja o liczbie akcji i głosów
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an official announcement under Polish corporate law providing the number of shares and voting rights ahead of the Ordinary General Meeting scheduled for June 23, 2026. It is not presenting financial results or reporting a meeting outcome but specifically “Voting Rights Announcement,” which matches code DVA.
2026-05-26 Polish
Wzór pełnomocnictwa dla akcjonariusza - wersja edytowalna
Regulatory Filings
2026-05-26 Polish
Formularz głosowania przez pełnomocnika - wersja .pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a proxy voting form (“Formularz wykonywania prawa głosu przez pełnomocnika”) including instructions for voting and the full text of proposed resolutions for the upcoming ordinary general meeting of shareholders of Bioceltix S.A. It is sent to shareholders to solicit votes and provide details of the agenda and draft resolutions. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-26 Polish
Wzór pełnomocnictwa dla akcjonariusza - wersja edytowalna
Regulatory Filings
2026-05-26 Polish
Wzór pełnomocnictwa dla akcjonariusza - wersja .pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a “WZÓR PEŁNOMOCNICTWA” – a template power‐of‐attorney (proxy form) for shareholders to appoint a proxy to attend and vote at the company’s Ordinary General Meeting. It is not financial results, not a report publication, but a proxy solicitation document. Under the taxonomy this fits “Proxy Solicitation & Information Statement” (PSI).
2026-05-26 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.